Xtant Medical Announces Appointment of Chief Financial Officer

Xtant Medical Announces Appointment of Chief Financial Officer

Healthcare Tech Outlook | Friday, November 30, 2018

BELGRADE, MT - Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development and commercialization of regenerative medicine products and medical devices, today announced the appointment of Kathie Lenzen as chief financial officer, effective August 20, 2018. Ms. Lenzen will report to Carl OConnell, Xtants chief executive officer.

Ms. Lenzen is an accomplished healthcare executive with significant financial expertise and we are pleased that she is joining our executive management team, said Carl OConnell. In addition to the financial leadership she will provide to the organization, she is a strong strategic, cross-functional leader. Her appointment continues our commitment to building a highly skilled management team.

Kathie Lenzen brings over 36 years of financial experience to Xtant. Most recently, Ms. Lenzen served as the senior vice president and general manager of Astora Womens Health division. Prior to being in this position, she was the vice president of finance for American Medical Systems and drove financial performance to ensure EBITDA growth consistently outpaced revenue growth. She is versed in cross-departmental collaboration from a financial perspective, knowledgeable about information systems, restructuring for profitability, and merger and acquisition activities.

I am excited to join the Xtant team and contribute to the Companys growth strategy, said Kathie Lenzen. Xtant has made considerable progress over the past year, and I look forward to helping the Company continue to transform its business and drive shareholder value.

Weekly Brief